Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Discovery
Sponsor : Candid Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Candid and Ab Studio Collaborate on T Cell Engagers for Autoimmune Disorders
Details : The companies entered a strategic research collaboration to discover and develop novel T Cell Engager program candidates for various autoimmune indications.
Product Name : Undisclosed
Product Type :
Upfront Cash : Undisclosed
December 16, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Discovery
Sponsor : Candid Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration